A Phase 2 Clinical Trial Assessing the Effect of BPZE1, a Novel Live Attenuated Pertussis Vaccine, in Healthy Adults
Tuesday, September 29, 2020 8:50 PM to 9:20 PM · 30 min. (Africa/Abidjan)
Emerging & Infectious Diseases
Platform Technology
Contract Research Organisation
Information
Topics
Topics
Clinical Ph 1 - 3
Infectious Diseases
ILiAD Biotechnologies
PPD
Registered attendees
Aernout Van Haarst
Director Of Scientific Affairs
Celerion
AW
Aiden Whitty
Conferences Coordinator
Clarivate Analytics
AR
Alexander Rumyantsev
Director, External Innovations
Sanofi Pasteur
See all (85)
Terrapinn UK
World Vaccine Congress Washington Virtual
Log in
Language
Organizing events?
Resource center
Contact app support
Legal notice
Terms of Use
Privacy Policy
Cookies Policy
Cookies consent
Home
WVC FULL Agenda
